Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

35 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Uptake of Adjuvant Durvalumab After Definitive Concurrent Chemoradiotherapy for Stage III Nonsmall-cell Lung Cancer.
Bryant AK, Yin H, Schipper MJ, Paximadis PA, Boike TP, Bergsma DP, Movsas B, Dess RT, Mietzel MA, Kendrick R, Seferi M, Dominello MM, Matuszak MM, Jagsi R, Hayman JA, Pierce LJ, Jolly S; Michigan Radiation Oncology Quality Consortium. Bryant AK, et al. Among authors: bergsma dp. Am J Clin Oncol. 2022 Apr 1;45(4):142-145. doi: 10.1097/COC.0000000000000899. Am J Clin Oncol. 2022. PMID: 35271524
Predictors of Pneumonitis After Conventionally Fractionated Radiotherapy for Locally Advanced Lung Cancer.
McFarlane MR, Hochstedler KA, Laucis AM, Sun Y, Chowdhury A, Matuszak MM, Hayman J, Bergsma D, Boike T, Kestin L, Movsas B, Grills I, Dominello M, Dess RT, Schonewolf C, Spratt DE, Pierce L, Paximadis P, Jolly S, Schipper M; Michigan Radiation Oncology Quality Consortium as part of the Blue Cross Blue Shield of Michigan and Blue Care Network of Michigan Value Partnerships Program. McFarlane MR, et al. Int J Radiat Oncol Biol Phys. 2021 Dec 1;111(5):1176-1185. doi: 10.1016/j.ijrobp.2021.07.1691. Epub 2021 Jul 24. Int J Radiat Oncol Biol Phys. 2021. PMID: 34314815
Disease Control After Hypofractionation Versus Conventional Fractionation for Triple Negative Breast Cancer: Comparative Effectiveness in a Large Observational Cohort.
Jagsi R, Griffith KA, Vicini FA, Abu-Isa E, Bergsma D, Bhatt A, Dilworth JT, Dominello M, Franklin S, Heimburger DK, Kaufman I, Kocheril PG, Kretzler AE, Paximadis P, Radawski JD, Walker EM, Pierce L. Jagsi R, et al. Int J Radiat Oncol Biol Phys. 2022 Mar 15;112(4):853-860. doi: 10.1016/j.ijrobp.2021.10.012. Epub 2021 Oct 28. Int J Radiat Oncol Biol Phys. 2022. PMID: 34718094 Free PMC article.
Association Between Physician- and Patient-Reported Symptoms in Patients Treated With Definitive Radiation Therapy for Locally Advanced Lung Cancer in a Statewide Consortium.
Wilkie JR, Hochstedler KA, Schipper MJ, Matuszak MM, Paximadis P, Dominello MM, Grills I, Hayman JA, Dess R, Dragovic AF, Jagsi R, Pierce LJ, Spratt DE, Bergsma D, Boike TP, Movsas B, Jolly S; Michigan Radiation Oncology Quality Consortium. Wilkie JR, et al. Int J Radiat Oncol Biol Phys. 2022 Mar 15;112(4):942-950. doi: 10.1016/j.ijrobp.2021.11.024. Epub 2021 Nov 26. Int J Radiat Oncol Biol Phys. 2022. PMID: 34838865 Clinical Trial.
Effect of Education and Standardization of Cardiac Dose Constraints on Heart Dose in Patients With Lung Cancer Receiving Definitive Radiation Therapy Across a Statewide Consortium.
Herr DJ, Hochstedler KA, Yin H, Dess RT, Matuszak M, Grubb M, Dominello M, Movsas B, Kestin LL, Bergsma D, Dragovic AF, Grills IS, Hayman JA, Paximadis P, Schipper M, Jolly S. Herr DJ, et al. Pract Radiat Oncol. 2022 Sep-Oct;12(5):e376-e381. doi: 10.1016/j.prro.2022.01.002. Epub 2022 Feb 1. Pract Radiat Oncol. 2022. PMID: 35121192
Racial Differences in Treatments and Toxicity in Patients With Non-Small-Cell Lung Cancer Treated With Thoracic Radiation Therapy.
Laucis AMB, Hochstedler KA, Schipper MJ, Paximadis PA, Boike TP, Bergsma DP, Movsas B, Kretzler A, Spratt DE, Dess RT, Mietzel MA, Dominello MM, Matuszak MM, Jagsi R, Hayman JA, Pierce LJ, Jolly S. Laucis AMB, et al. Among authors: bergsma dp. JCO Oncol Pract. 2022 Jun;18(6):e1034-e1044. doi: 10.1200/OP.21.00224. Epub 2022 Feb 15. JCO Oncol Pract. 2022. PMID: 35167337
Cardiac and Pulmonary Dosimetric Parameters in Patients With Lung Cancer Undergoing Postoperative Radiation Therapy Across a Statewide Consortium.
Herr DJ, Yin H, Allen SG, Bergsma D, Dragovic AF, Dess RT, Matuszak M, Grubb M, Dominello M, Movsas B, Kestin LL, Hayman JA, Paximadis P, Schipper M, Jolly S; Michigan Radiation Oncology Quality Consortium. Herr DJ, et al. Pract Radiat Oncol. 2023 May-Jun;13(3):e254-e260. doi: 10.1016/j.prro.2023.01.010. Epub 2023 Feb 6. Pract Radiat Oncol. 2023. PMID: 36754278
Prospective Evaluation of Limited-Stage Small Cell Lung Cancer Radiotherapy Fractionation Regimen Usage and Acute Toxicity in a Large Statewide Quality Collaborative.
Allen SG, Dragovic AF, Yin HM, Bryant AK, Paximadis PA, Matuszak MM, Schipper MJ, Dess RT, Hayman JA, Dominello MM, Kestin LL, Movsas B, Jolly S, Bergsma DP; Michigan Radiation Oncology Quality Consortium. Allen SG, et al. Among authors: bergsma dp. Pract Radiat Oncol. 2023 Sep-Oct;13(5):444-453. doi: 10.1016/j.prro.2023.04.007. Epub 2023 Apr 24. Pract Radiat Oncol. 2023. PMID: 37100388
Factors associated with acute esophagitis during radiation therapy for lung cancer.
Herr DJ, Yin H, Bergsma D, Dragovic AF, Matuszak M, Grubb M, Dominello M, Movsas B, Kestin LL, Boike T, Bhatt A, Hayman JA, Jolly S, Schipper M, Paximadis P; Michigan Radiation Oncology Quality Consortium. Herr DJ, et al. Radiother Oncol. 2024 May 28;197:110349. doi: 10.1016/j.radonc.2024.110349. Online ahead of print. Radiother Oncol. 2024. PMID: 38815695
35 results